Patent · US Active

Methods and compositions for treatment of a genetic condition

US9902974B2 · kind B2 · utility

28Cited by

32References

7Claims

0Family size

Assignee

Sangamo Therapeutics, Inc. · US

Inventors

Anthony J. Conway · Chatfield, US
Gregory J. Cost · Berkeley, US
Russell DeKelver · Daly City, US
Edward J. Rebar · Richmond, US
Andreas Reik · Richmond, US
Fyodor Urnov · Richmond, US
Jianbin Wang · Richmond, US
H. Steve Zhang · Richmond, US

Key dates

Filing date	Dec 10, 2015
Grant date	Feb 27, 2018
Priority date	—
Expiry date	Dec 10, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y301/21004
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods and compositions comprising a fusion protein comprising a Cas protein and a functional domain in association with a single guide RNA targeted to an endogenous gene for genetic alteration of cells are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.